August 7 (SeeNews) - The net profit of Romanian state-controlled drug maker Antibiotice [BSE:ATB] dropped to 16.1 million lei ($4.9 million/3.7 million euro) in the first half of 2013 from 25.7 million lei a year earlier, the company said.